TrK Neurotrophin Receptors in Cholinergic Neurons of patients with Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 1, 1997, Pages 1-8

  Boissiere F ^a   Hunot, S ^a   Faucheux, B ^a   Hersh, L B ^b   Agid, Y ^a   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer s disease; Choline acetyltransferase; Human brain; Nerve growth factor receptors; Nucleus basalis of Meynert; Striatum

Indexed keywords

CHOLINE ACETYLTRANSFERASE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; PROTEIN TYROSINE KINASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINERGIC FIBERS; CORPUS STRIATUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; SUBSTANTIA INNOMINATA;

EID: 0031002191     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106594     Document Type: Article

References (42)

1. Whitehousc PJ, Price DL, Clark AW, Coyle JT, DeLong MR: Alzheimer disease: Evidence for a selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981:10:122-126.
2. Etienne P. Robitaille Y, Wood P, Gauthier S, Nair NPV, Quirion R: Nucleus basalis neuronal loss, ncuritic plaques and choline acctyl-transferase activity in advanced Alzheimer's disease. Neuroscience 1986:19:1279-1291.
3. Lehericy S, Hirsch EC, Cervera-Pierot P, Hcrsh LB, Bakchinc S. Piettc F, Duyckacrts C, Hauw JJ, Javoy-Agid F, Agid Y: Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer’s disease. J Comp Neurol 1993; 330:15-31.
4. 3H vcsami-col binding in the temporal cortex of patients with Alzheimer's disease. Parkinson's disease, and rats with basal forcbrain lesions. Neuroscience 1990;35:327-333.
5. Lehericy S, Hirsch EC, Cervcra P. Hcrsh LB. Hauw JJ. Ruberg M. Agid Y: Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer's disease. Proc Nall AcadSci USA 1989;86:8580-8584.
6. Woolf NJ, Jacobs RW, Butcher LL: The pon-tomescncephalotcgmenlal cholinergic system docs not degenerate in Alzheimer's disease. NeurosciLetl 1989;96:277-282.
7. Hartikka J. Hefti F: Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro. J Ncurosci Res 198S;21:352-364.
8. Kniisel B, Hefti F: Nerve growth factor promotes development of rat forcbrain but not pcdunculopontine cholinergic neurons in vitro: Lack of effect of ciliary ncurotrophic factor and relinoic acid. J Ncurosci Res 1988:21:365-375.
9. Fischer W, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH: Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987;329:65-68.
10. Kromcr LF: Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987;235:214-216.
11. Barbacid M: The Trk family of ncurotrophin receptors. J Neurobiol 1994;25:1386-1403.
12. Dechant G, Rodriguez-Tebar A, Barde YA: Ncurotrophin receptors. Prog Neurobiol 1994; 42:347-352.
13. Woolf NJ, Gould E, Butcher LL: Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pon-tomesencephalon. Neuroscience 1989;30:143-152.
14. Hcfti F, Mash DC: Localization of nerve growth factor receptors in the normal human brain and in Alzheimer’s disease. Neurobiol Aging 1989;10:75-87.
15. Mufson EJ, Bothwell M, Hersh LB. Kordower HJ: Nerve growth factor receptor in the normal, aged human basal forebrain: Colocalization with cholinergic neurons. J Comp Neurol 1989;285:196-217.
16. Allen SJ. Dawbam D, MacGowan SH, Wilcock GK, Treanor JJS. MossTH: Quantitative mor-phometric analysis of basal forebrain neurons expressing nerve growth factor receptors in normal and Alzheimer’s disease brains. Dementia 1990;1:125-137.
17. Strada O, Hirsch EC, Javoy-Agid F, Lehericy S, Ruberg M, Hauw JJ, Agid Y: Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain. J Ncurosci 1992; 12:4766-4774.
18. Boissiere F, Hunot S, Fauchcux B, Mouatt-Pri-gent A, Agid Y, Hirsch EC: High affinity neuro-trophin receptors in cholinergic neurons in the human brain. C R Acad Sei Paris 1994:318: 997-1003.
19. Goedcrt M, Fine A, Dawbam D, Wilcock GK, Chao MV: Nerve growth factor receptor mRNA distribution in human brain: Normal levels in basal forebrain in Alzheimer’s disease. Mol Brain Res 1989;5:1-7.
20. Bertrand P, Roger O, Houlgalte R, Javoy-Agid F, Brandcl JP, Doble A, Blanchard JC: Measurement of nerve growth factor-like immuno-rcactivity in the human brain using an anti-mouse-NGF enzyme immunoassay. Neuro-chemlnt 1992;20:215-218.
21. Mufson EJ, Bothwell M, Kordower JH: Loss of nerve growth factor receptor-containing neurons in Alzheimer’s disease: A quantitative analysis across subregions of the basal forebrain. Exp Neurol 1989;105:221-232.
22. Gocdert M, Fine A, Hunt SP, Ullrich A: Nerve growth factor rnRNA in the peripheral and central rat tissues and in human central nervous system: Lesion effects in the rat brain and levels in Alzheimer's disease. Mol Brain Res 1986; 1:85-92.
23. Emfors P, Linderfors N, Chan-Palay V, Pers-son H: Cholinergic neurons of the nucleus basal is express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia 1990; 1:138-145.
24. McKliann G. Drachman D, Folstcin M, Katz-man R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939-944.
25. Bodian D: A new method for staining nerve fibres and nerve endings in mounted paraffin sections. Anal Rcc 1936;65:89-98.
26. Ransmayr G, Ccrvcra P, Hirsch E, Ruberg M, Hersh LB, Duyckaerts C, Hauw JJ, Dclumeau C, Agid Y: Choline acctyltransferase-likc im-munoreactivity in the hippocampal formation of control subjects and patients with Alzheimer’s disease. Neuroscience 1989;32:701-714.
27. Mesulam MM, Mufson EJ, Wainer BH, Levey AJ: Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch 1—Ch6). Neuroscience 1983;10:1185-1201.
28. Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F: Glutathione peroxidase, glial cells and Parkinson’s disease. Neuroscience 1993;52:1-6.
29. Hirsch EC, Graybiel AM. Duyckaerts C, Agid Y: Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acctyltransfcrase in the human striatum. Neurosci Lett 1989;96:145-150.
30. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M: Molecular and biochemical characterization of the humanirkproto-onco-gene. Mol Cell Biol 1989:9:24-33.
31. Graybiel AM, Ragsdale CW: Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc Natl Acad Sci USA 1978;75:5723-5726.
32. Steininger TL, Wainer BH, Klein R, Barbacid M, Palfrey HC: High-affinity nerve growth factor receptor (Trk) immunorcactivity is localized in cholinergic neurons of the basal fore-brain and striatum in the adult rat brain. Brain Res 1993:612:330-335.
33. Kordower JH, Chen E, Sladek JR, Mufson EJ: Trk immunoreactivity in the monkey central nervous system: Forcbrain. J Comp Neurol 1994;349:20-35.
34. Mcrlio JP, Emfors P, Jaber M, Pcrsson H: Molecular cloning of ratIrkCand distribution of cells expressing messenger RNAs for members of theIrkfamily in the rat central nervous system. Neuroscience 1992;51:513-532.
35. Knüsel B. Michel PP. Schwaber JS. Hefti F: Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Ncurosci 1990;10:558-570.
36. Dekker AJ, Winkler J, Thal LJ, Gage FH: Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellu-laris. Neuroscience 1994;60:299-309.
37. Crowley C. Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, McMahon SB, Shelton DL, Levinson AD, Phillips HS: Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forcbrain cholinergic neurons. Cell 1994;76:1001-1011.
38. Smeyne R, Klein R, Schnapp A, Long L, Bryant S, Lewin A, Lira SA, Barbacid M: Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 1994;368:246-249.
39. Davies P: Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 1979;171:319-327.
40. Strada O, Vyas S, Hirsch EC, Ruberg M, Brice A, Agid Y, Javoy-Agid F: Decreased choline acctyltransfcrase mRNA expression in the nucleus basalis of Mcyncrt in Alzheimer disease: An in situ hybridization study. Proc Natl Acad Sci USA 1992;89:9549-9553.
41. Rossor MN, Garret NJ. Johnson AL, Mountjoy CQ, Roth M, Iversen LL: A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 1982;105:313-330.
42. Seiden N, Mesulam MM, Geula C: Human striatum: The distribution of neurofibrillary tangles in Alzheimer's disease. Brain Res 1994; 648:327-331.